Turmoil at 23andMe, a company offering popular at-home DNA testing, has upset the industry. Following the resignation of every independent member of the company’s board of directors, its chief ...
Many FDA-regulated companies are exploring ways to support diagnostic testing, especially when early diagnosis can impact treatment options. However, funding diagnostic testing tied to a company’s own ...
Six years after the fall of Theranos, companies are again exploring innovation in blood testing. The medical community is reacting with cautious optimism. Six years after the fall of Theranos, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results